Found: 54
Select item for more details and to access through your institution.
New indications.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 494
- Publication type:
- Article
FDA actions in briefs.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 494
- Publication type:
- Article
Recommendations for approval.
- Published in:
- 2002
- Publication type:
- Journal Article
Approvable designations.
- Published in:
- 2002
- Publication type:
- Journal Article
Fast-track designations.
- Published in:
- 2002
- Publication type:
- Journal Article
Priority review.
- Published in:
- 2002
- Publication type:
- Journal Article
FDA actions in brief.
- Published in:
- 2002
- Publication type:
- Journal Article
First-time generics.
- Published in:
- 2002
- Publication type:
- Journal Article
Is nicotine replacement therapy an effective long-term smoking cessation aid?
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 501
- Publication type:
- Article
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 501
- Publication type:
- Article
Letter highlights mental side-effects update on antimalarial.
- Published in:
- 2002
- Publication type:
- Journal Article
HRT updates reflect WHI results.
- Published in:
- 2002
- Publication type:
- Journal Article
Is nicotine replacement therapy an effective long-term smoking cessation aid?
- Published in:
- 2002
- Publication type:
- Journal Article
New labeling highlights superior safety profile on Malarone.
- Published in:
- 2002
- Publication type:
- Journal Article
Brief reports.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 502
- Publication type:
- Article
Public Citizen says Alzheimer's 'ADAPT' study should be stopped.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 502
- Publication type:
- Article
Smoking lowers response to infliximab in patients with Crohn's disease.
- Published in:
- 2002
- Publication type:
- Journal Article
Long-term Depo-Provera use could increase cardiovascular disease risk.
- Published in:
- 2002
- Publication type:
- Journal Article
Public Citizen says Alzheimer's 'ADAPT' study should be stopped.
- Published in:
- 2002
- Publication type:
- Journal Article
...But bone loss in Depo-Provera users is largely reversible.
- Published in:
- 2002
- Publication type:
- Journal Article
Metroprolol: High or low dose is beneficial in patients with heart failure.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 503
- Publication type:
- Article
Metoprolol: high or low dose is beneficial in patients with heart failure.
- Published in:
- 2002
- Publication type:
- Journal Article
Xendos study: Orlistat plus diet prevents, delays diabetes onset in obese patients.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 504
- Publication type:
- Article
Fatal heart attacks: Generic captopril as effective as losartan.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 504
- Publication type:
- Article
Xendos study: Orlistat plus diet prevents, delays diabetes onset in obese patients.
- Published in:
- 2002
- Publication type:
- Journal Article
Fatal heart attacks: generic captopril as effective as losartan.
- Published in:
- 2002
- Publication type:
- Journal Article
news in brief.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 505
- Publication type:
- Article
Eye on the literature.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 505
- Publication type:
- Article
Arixtra: Four weeks of Tx significantly reduces DVT/PE risk in hip fracture patients.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 505
- Publication type:
- Article
Pfizer launches free medicine program.
- Published in:
- 2002
- Publication type:
- Journal Article
Investigational anticholinergic superior to salmeterol for COPD.
- Published in:
- 2002
- Publication type:
- Journal Article
Recently published guidelines.
- Published in:
- 2002
- Publication type:
- Journal Article
Arixtra: four weeks of Tx significantly reduces DVT/PE risk in hip fracture patients.
- Published in:
- 2002
- Publication type:
- Journal Article
Open study shows TNF blockers superior to pyrimidine synthesis inhibitor for RA.
- Published in:
- 2002
- Publication type:
- Journal Article
Cohort analysis helps clinch superiority of efavirenz-containing HIV therapy.
- Published in:
- 2002
- Publication type:
- Journal Article
New agent shown more effective than enoxaparin for reducing VTE after major orthopedic surgery.
- Published in:
- 2002
- Publication type:
- Journal Article
Drug and Formulary Trends.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 513
- Publication type:
- Article
Postmarketing drug dosage changes of NMEs approved between 1980-1999.
- Published in:
- 2002
- Publication type:
- Journal Article
Patients' concerns when entering the health system.
- Published in:
- 2002
- Publication type:
- Journal Article
Potential cost savings from pill splitting.
- Published in:
- 2002
- Publication type:
- Journal Article
Drug and formulary factoids.
- Published in:
- 2002
- Publication type:
- Journal Article
Eplerenone: the first selective aldosterone receptor antagonist for the treatment of hypertension.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Eplerenone.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 514
- By:
- Publication type:
- Article
Evidence-based medicine: what it is, why to use it, and how to incorporate it into decision-making.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Evidence-based medicine: What it is, why to use it, and how to incorporate it into decision-making.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 525
- By:
- Publication type:
- Article
How to communicate effectively with your organization's 'C' suite--the CFO, CEO, COO.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 531
- Publication type:
- Article
How to communicate effectively with your organization's 'C' suite---the CFO, CEO, COO.
- Published in:
- 2002
- Publication type:
- Journal Article
Study examines economic impact of fixed-dose combination therapies for hypertension.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 539
- Publication type:
- Article
Beta blocker compliance program proves successful, gives plan sponsors needed ROI.
- Published in:
- Formulary, 2002, v. 37, n. 10, p. 539
- Publication type:
- Article
Study examines economic impact of fixed-dose combination therapies for hypertension.
- Published in:
- 2002
- Publication type:
- Journal Article